In the context of cancer, albumin levels can be an important biomarker for assessing nutritional status and disease progression. Cancer patients often experience malnutrition and cachexia, which can lead to reduced albumin levels. Low albumin levels in cancer patients are associated with poor prognosis and can indicate advanced disease stages or increased inflammation.
